TY  - JOUR 
AU  - Gaibar Alonso, María
AU  - Beltrán, Laura
AU  - Romero-Lorca, Alicia
AU  - Fernández-Santander, Ana
AU  - Novillo, Apolonia
PY  - 2020
SN  - 1687-8450
UR  - http://hdl.handle.net/20.500.12020/1827
AB  - In one of every four or five cases of breast cancer, the human epidermal growth factor receptor-2 (HER2) gene is overexpressed. These carcinomas are known as HER2-positive. HER2 overexpression is linked to an aggressive phenotype and a lower rate of...
LA  - en
PB  - Hindawi-Wiley
TI  - Somatic mutations in HER2 and implications for current treatment paradigms in HER2-positive breast  cancer
DO  - https://doi.org/10.1155/2020/6375956
T2  - Journal of Oncology
M2  - 1
KW  - HER2-positive breast cancer
KW  - Resistance to anti-HER2 therapy
KW  - Polymorphisms
KW  - Anti-HER2 therapy
KW  - Biomarkers
ER  -